Advertisement

Topics

Themis Bioscience Company Profile

18:07 EDT 19th June 2018 | BioPortfolio

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating disease with global outbreak potential. Our innovation in vaccine and immune activation technology has created a powerful platform and a growing pipeline addressing a broad range of infectious diseases. Together with industrial and academic leaders we work to prevent illness across the globe. For more information, visit http://www.themisbio.com.


News Articles [268 Associated News Articles listed on BioPortfolio]

$37.5 million investment in Austrian vaccines developer Themis Bioscience

A new partnership between Austrian biotech Themis Bioscience and Oslo-based CEPI – the Coalition for…

Themis raises €10mm in Series C round

Themis Bioscience GMBH raised €10mm ($12mm) in its Series C financing led by Global Health Investment Fund, which adds a board member and was joined by returning shareholders aws Gruenderfonds, Omne...

CHIKUNGUNYA VACCINE DEVELOPMENT TOWARDS PHASE III TRIALS BOOSTED BY INNOVATE UK

Vienna, 5th September 2017 – The further development of a promising Chikungunya vaccine candidate by Themis Bioscience is now supported with 3 Mio. GBP by the United Kingdom’s innovation agenc...

EMA grants PRIME designation to Themis' chikungunya vaccine candidate

Themis announced today that the European Medicines Agency has granted PRIority MEdicines designation to its most advanced program in development, a vaccine to prevent chikungunya fever.

Themis Bioscience Reaps Bill Gates' Backed CEPI Funding For Lassa Fever And MERS Vaccines

Plans to have candidate vaccines ready for testing against infectious diseases during an evolving epidemic have taken a step forward...   

Themis Receives EMA PRIME Designation for Chikungunya Vaccine

Themis announced today that the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) designation to its most advanced program in development, a vaccine to...

Austrian Vaccines Biotech Closes €10M Series C to Stop Global Outbreaks

Austrian biotech Themis has received a financial boost for the development of its vaccines against infections like Chikungunya, which could be the next big global outbreak. Themis, which specializes ...

Arix Bioscience Plc - Director/PDMR Shareholding

Arix Bioscience Plc - Director/PDMR Shareholding PR Newswire London, June 11 ARIX BIOSCIENCE PLC Director/PDMR Shareholding Arix Bioscience plc today announces the annual award of nil cost options...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

O24 [Revive Bioscience, Inc.]

Abraxane [Abraxis BioScience, LLC]

These highlights do not include all the information needed to use ABRAXANE safely and effectively. See full prescribing information for ABRAXANE ABRAXANE® for Injectable Suspension (paclitaxel protei...

Idkit hp one [Exalenz Bioscience Ltd.]

Package Insert IDkit:Hp™ for the Exalenz BreathID® System BREATH TEST FOR DETECTION of H. pylori

PubMed Articles [56 Associated PubMed Articles listed on BioPortfolio]

The nursification of a bioscience unit and its impact on student satisfaction and learning in an undergraduate nursing degree.

Undergraduate nursing students traditionally find bioscience difficult, which can be compounded by an inability to relate bioscience theory to nursing practice. Subsequently, many registered nurses fe...

Corrigendum.

Happy Birthday Karel!

Anarchy in the UPR: A Ca-insensitive PKC inhibits SERCA activity to promote ER stress.

Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in Western countries, and is linked to the development of liver cancer and Type 2 diabetes (T2D). It is strongly associated with obesity, b...

Youtube for millennial nursing students; using internet technology to support student engagement with bioscience.

Undergraduate nursing programs typically include students with limited 'on-campus' time who need learning resources that are flexible, technologically appropriate, remotely-accessible (mobile smart de...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

Metabolic syndrome increases the risk for development of heart disease. Another condition associated with metabolic syndrome is fatty liver disease which is also referred to as nonalcoholi...

Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCI

To date there is very little PD and pharmacokinetic (PK) data on the ticagrelor 60 mg bid dosing regimen. In particular, there is no prospective PK/PD study on this dosing regimen in patie...

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

This pilot study will try to minimize the pain during exposure to a new red light source (RhodoLED®, Biofrontera Bioscience GmbH, Leverkusen, Germany) used for PDT without compromising it...

Skin Safety Profile of Different Exposure to the Light Emitting Diode (LED) in Healthy Subjects

Photomodulation is a process which manipulates or regulates cell activity using light sources without thermal effect. Different studies have investigated the use of non-thermal low dose li...

Companies [309 Associated Companies listed on BioPortfolio]

Themis Bioscience

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating...

Themis

Themis is developing urgently needed vaccines to prevent death and disability around the world. We lead in the development of a vaccine against chikungunya, a serious debilitating...

The Idaho Bioscience Association

The Idaho Bioscience Association is a non-profit organization that brings together corporate, academic and political leaders to educate the public and to promote bioscience activities in the state. B...

Sprint Bioscience

Sprint Bioscience AB (publ) is part of the new Swedish pharmaceutical industry. The company has the goal to develop drug candidates for the global pharmaceutical market within the...

Bioscience Bridge, LLC

Bioscience Bridge, LLC is a global technology transfer agency. We accelerate the connections of university-based bioscience research with commercial development opportunities. We are unique because we...

More Information about "Themis Bioscience" on BioPortfolio

We have published hundreds of Themis Bioscience news stories on BioPortfolio along with dozens of Themis Bioscience Clinical Trials and PubMed Articles about Themis Bioscience for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Themis Bioscience Companies in our database. You can also find out about relevant Themis Bioscience Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record